Our Products
We are leaders in the market for providing best range of Ponatinib 15mg & 45mg (Iclusig) 30 Tablets
Ponatinib is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia ( CML) that is resistant or intolerant to prior TKI therapy or philadelphia chromose positive acute lymbhoblastic leukemia (PH+ ALL) that is resistant or intolerant to prior TKI therapy
Additional Information:
Payment Terms : T/T, Western Union
Packaging Details : Film Coated Tablets